{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:12:41Z","timestamp":1782958361197,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["2014\/407830-0; SPHQ 14-APW-259"],"award-info":[{"award-number":["2014\/407830-0; SPHQ 14-APW-259"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["AFP surveillance in Italy. Search of poliovirus in patients with immune deficiency and in the environment"],"award-info":[{"award-number":["AFP surveillance in Italy. Search of poliovirus in patients with immune deficiency and in the environment"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1587-y","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T13:29:58Z","timestamp":1465565398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis"],"prefix":"10.1186","volume":"16","author":[{"given":"Thomas","family":"Foiadelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Savasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Battistone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majlinda","family":"Kota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Passera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luigi","family":"Marseglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,10]]},"reference":[{"key":"1587_CR1","first-page":"242","volume":"63","author":"OM Diop","year":"2014","unstructured":"Diop OM, Burns CC, Wassilak SG, Kew OM. Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013. MMWR Morb Mortal Wkly Rep. 2014;63:242\u20138. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6311a5.htm . [Accessed 6 May 2016].","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1587_CR2","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","volume":"210 Suppl","author":"LR Platt","year":"2014","unstructured":"Platt LR, Est\u00edvariz CF, Sutter RW. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. J Infect Dis. 2014;210 Suppl:S380\u20139.","journal-title":"J Infect Dis"},{"issue":"Suppl","key":"1587_CR3","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","volume":"210","author":"CC Burns","year":"2014","unstructured":"Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014;210(Suppl):S283\u201393.","journal-title":"J Infect Dis"},{"key":"1587_CR4","first-page":"6","volume":"2014","author":"WHO","year":"2014","unstructured":"WHO. Classification of AFP cases, surveillance performance and weekly reporting by country to WHO European Regional Office, 2013\u20132014. In WHO EpiData. 2014;2014:6. http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0004\/262183\/EpiData-8-2014.pdf . [Accessed 6 May 2016].","journal-title":"In WHO EpiData"},{"key":"1587_CR5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archpedi.1994.02170050037007","volume":"148","author":"DR Prevots","year":"1994","unstructured":"Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med. 1994;148:479\u201385.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1587_CR6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","volume":"59","author":"OM Kew","year":"2005","unstructured":"Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587\u2013635.","journal-title":"Annu Rev Microbiol"},{"key":"1587_CR7","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1086\/379791","volume":"188","author":"N Khetsuriani","year":"2003","unstructured":"Khetsuriani N, Prevots DR, Quick L, Elder ME, Pallansch M, Kew O, et al. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. J Infect Dis. 2003;188:1845\u201352.","journal-title":"J Infect Dis"},{"key":"1587_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biologicals.2006.02.005","volume":"34","author":"J Mart\u00edn","year":"2006","unstructured":"Mart\u00edn J. Vaccine-derived poliovirus from long term excretors and the end game of polio eradication. Biologicals. 2006;34:117\u201322.","journal-title":"Biologicals"},{"issue":"Suppl","key":"1587_CR9","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1093\/infdis\/175.Supplement_1.S176","volume":"175","author":"JP Alexander","year":"1997","unstructured":"Alexander JP, Gary HE, Pallansch MA. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis. 1997;175(Suppl):S176\u201382.","journal-title":"J Infect Dis"},{"key":"1587_CR10","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1128\/JVI.78.24.13839-13847.2004","volume":"78","author":"J Mart\u00edn","year":"2004","unstructured":"Mart\u00edn J, Odoom K, Tuite G, Dunn G, Hopewell N, Cooper G, et al. Long-term excretion of vaccine-derived poliovirus by a healthy child. J Virol. 2004;78:13839\u201347.","journal-title":"J Virol"},{"key":"1587_CR11","unstructured":"Fiore L, Buttinelli G, Fiore S. Acute flaccid paralysis surveillance and monitoring of circulation of polio and other enteroviruses in Italy. Roma Ist Super di Sanit\u00e0 Rapp ISTISAN 13\/44 2013. http:\/\/www.iss.it\/publ\/index.php?id=2788&tipo=5&lang=1 . [Accessed 6 May 2016]."},{"key":"1587_CR12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/A:1007697421114","volume":"15","author":"L Fiore","year":"1999","unstructured":"Fiore L, Novello F, Simeoni P, Amato C, Vellucci L, De Stefano D, et al. Surveillance of acute flaccid paralysis in Italy: 1996\u201397. Eur J Epidemiol. 1999;15:757\u201376.","journal-title":"Eur J Epidemiol"},{"key":"1587_CR13","first-page":"99","volume":"12","author":"L Fiore","year":"2000","unstructured":"Fiore L, Novello F, Simeoni P, Amato C, Buttinelli G, Fiore S, et al. Epidemiology of acute flaccid paralysis in Italy: 1996\u201398. Group for the Study of AFP. Ann Ig. 2000;12:99\u2013110.","journal-title":"Ann Ig"},{"issue":"4 Suppl 5","key":"1587_CR14","first-page":"1","volume":"14","author":"AM Patti","year":"2002","unstructured":"Patti AM, Santi AL, Vulcano A, Casagni L, Lamberti A, De Stefano CD, et al. Surveillance of poliomyelitis in Italy: immunity status of population against polio and environmental circulation of Poliovirus. General illustration of the results. Ann Ig. 2002;14(4 Suppl 5):1\u201357.","journal-title":"Ann Ig"},{"key":"1587_CR15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(01)05399-5","volume":"358","author":"PD Minor","year":"2001","unstructured":"Minor PD. Biosafety consequences of eradication of wild-type polioviruses. Lancet. 2001;358:166\u20138.","journal-title":"Lancet"},{"key":"1587_CR16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1099\/vir.0.18974-0","volume":"84","author":"G Buttinelli","year":"2003","unstructured":"Buttinelli G, Donati V, Fiore S, Marturano J, Plebani A, Balestri P, et al. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J Gen Virol. 2003;84:1215\u201321.","journal-title":"J Gen Virol"},{"key":"1587_CR17","unstructured":"Fiore L, Buttinelli G, Fiore S. Acute flaccid paralysis surveillance and monitoring of circulation of polio and other enteroviruses in Italy. ISTISAN Reports. 2013;13\/44:101 http:\/\/www.iss.it\/binary\/publ\/cont\/13_44_web.pdf . [Accessed 6 May 2016]."},{"key":"1587_CR18","volume-title":"Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings","author":"J Siegel","year":"2007","unstructured":"Siegel J, Rhinehart E, Jackson M, Chiarello L, the Healthcare Control Practices Advisory Committee. Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. 2007. http:\/\/www.cdc.gov\/hicpac\/pdf\/isolation\/Isolation2007.pdf . [Accessed 6 May 2016]."},{"key":"1587_CR19","unstructured":"WHO. Polio Laboratory Manual. WHO\/IVB\/04.10. Geneva, Switzerland: World Health Organization; 2004."},{"key":"1587_CR20","unstructured":"Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT. In: Nucleic Acids Symposium Series. Volume 41. Ed. New York, NY: Oxford University Press; 1999. p. 95\u201398."},{"key":"1587_CR21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","volume":"10","author":"LA Kelley","year":"2015","unstructured":"Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10:845\u201358.","journal-title":"Nat Protoc"},{"key":"1587_CR22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a009924","volume":"150","author":"PE Fine","year":"1999","unstructured":"Fine PE, Carneiro IA. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. Am J Epidemiol. 1999;150:1001\u201321.","journal-title":"Am J Epidemiol"},{"key":"1587_CR23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/j.1460-2075.1994.tb06336.x","volume":"13","author":"AJ Macadam","year":"1994","unstructured":"Macadam AJ, Ferguson G, Fleming T, Stone DM, Almond JW, Minor PD. Role for poliovirus protease 2A in cap independent translation. EMBO J. 1994;13:924\u20137.","journal-title":"EMBO J"},{"key":"1587_CR24","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1128\/JVI.74.7.3001-3010.2000","volume":"74","author":"J Mart\u00edn","year":"2000","unstructured":"Mart\u00edn J, Dunn G, Hull R, Patel V, Minor PD. Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol. 2000;74:3001\u201310.","journal-title":"J Virol"},{"key":"1587_CR25","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1128\/JVI.63.3.1302-1309.1989","volume":"63","author":"N Kawamura","year":"1989","unstructured":"Kawamura N, Kohara M, Abe S, Komatsu T, Tago K, Arita M, et al. Determinants in the 5\u2019 noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol. 1989;63:1302\u20139.","journal-title":"J Virol"},{"issue":"12","key":"1587_CR26","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1099\/0022-1317-73-12-3065","volume":"73","author":"PD Minor","year":"1992","unstructured":"Minor PD. The molecular biology of poliovaccines. J Gen Virol. 1992;73(12):3065\u201377.","journal-title":"J Gen Virol"},{"key":"1587_CR27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.virusres.2008.07.006","volume":"137","author":"S Shahmahmoodi","year":"2008","unstructured":"Shahmahmoodi S, Parvaneh N, Burns C, Asghar H, Mamishi S, Tabatabaie H, et al. Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia. Virus Res. 2008;137:168\u201372.","journal-title":"Virus Res"},{"key":"1587_CR28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1086\/421703","volume":"190","author":"CV Martinez","year":"2004","unstructured":"Martinez CV, Old MO, Kwock DK, Khan SS, Garcia JJ, Chan CS, et al. Shedding of sabin poliovirus Type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine. J Infect Dis. 2004;190:409\u201316.","journal-title":"J Infect Dis"},{"key":"1587_CR29","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/j.1460-2075.1989.tb03541.x","volume":"8","author":"DJ Filman","year":"1989","unstructured":"Filman DJ, Syed R, Chow M, Macadam AJ, Minor PD, Hogle JM. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 1989;8:1567\u201379.","journal-title":"EMBO J"},{"key":"1587_CR30","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1128\/JVI.65.10.5225-5231.1991","volume":"65","author":"AJ Macadam","year":"1991","unstructured":"Macadam AJ, Ferguson G, Arnold C, Minor PD. An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain. J Virol. 1991;65:5225\u201331.","journal-title":"J Virol"},{"key":"1587_CR31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/aje\/kwi033","volume":"161","author":"N Nathanson","year":"2005","unstructured":"Nathanson N. David Bodian\u2019s contribution to the development of poliovirus vaccine. Am J Epidemiol. 2005;161:207\u201312.","journal-title":"Am J Epidemiol"},{"key":"1587_CR32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/08820139.2013.859156","volume":"43","author":"M Shaghaghi","year":"2014","unstructured":"Shaghaghi M, Parvaneh N, Ostad-Rahimi P, Fathi SM, Shahmahmoodi S, Abolhassani H, et al. Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature. Immunol Invest. 2014;43:292\u20138.","journal-title":"Immunol Invest"},{"key":"1587_CR33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0042-6822(88)90113-4","volume":"167","author":"N Cammack","year":"1988","unstructured":"Cammack N, Phillips A, Dunn G, Patel V, Minor PD. Intertypic genomic rearrangements of poliovirus strains in vaccinees. Virology. 1988;167:507\u201314.","journal-title":"Virology"},{"key":"1587_CR34","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/JCM.36.10.2893-2899.1998","volume":"10","author":"OM Kew","year":"1998","unstructured":"Kew OM, Sutter RW, Nottay BK, McDonough MJ, Prevots DR, Quick L, et al. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol. 1998;10:2893\u20139.","journal-title":"J Clin Microbiol"},{"key":"1587_CR35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/viro.1999.0003","volume":"265","author":"A Bellmunt","year":"1999","unstructured":"Bellmunt A, May G, Zell R, Pring-Akerblom P, Verhagen W, Heim A. Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology. 1999;265:178\u201384.","journal-title":"Virology"},{"issue":"8","key":"1587_CR36","doi-asserted-by":"crossref","first-page":"e1005114","DOI":"10.1371\/journal.ppat.1005114","volume":"11","author":"G Dunn","year":"2015","unstructured":"Dunn G, Klapsa D, Wilton T, Stone L, Minor PD, Martin J. Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative. PLoS Pathog. 2015;11(8):e1005114.","journal-title":"PLoS Pathog"},{"issue":"10","key":"1587_CR37","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.vaccine.2015.01.018","volume":"33","author":"J Guo","year":"2015","unstructured":"Guo J, Bolivar-Wagers S, Srinivas N, Holubar M, Maldonado Y. Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication. Vaccine. 2015;33(10):1235\u201342.","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"1587_CR38","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.1093\/infdis\/jiu065","volume":"210","author":"L Li","year":"2014","unstructured":"Li L, Ivanova O, Driss N, Tiongco-Recto M, da Silva R, Shahmahmoodi S, et al. Poliovirus Excretion Among Persons With Primary Immune Deficiency Disorders: Summary of a Seven-Country Study Series. J Infect Dis. 2014;210 Suppl 1:S368\u201372.","journal-title":"J Infect Dis"},{"key":"1587_CR39","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.11150\/kansenshogakuzasshi1970.75.1030","volume":"75","author":"N Morimoto","year":"2001","unstructured":"Morimoto N. The relationship between poliovirus multiplication, the sIgA antibody response and the serum neutralizing antibody titers after trivalent oral polio vaccination. Kansenshogaku Zasshi. 2001;75:1030\u20139.","journal-title":"Kansenshogaku Zasshi"},{"key":"1587_CR40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virol.2005.09.015","volume":"344","author":"VR Racaniello","year":"2006","unstructured":"Racaniello VR. One hundred years of poliovirus pathogenesis. Virology. 2006;344:9\u201316.","journal-title":"Virology"},{"key":"1587_CR41","first-page":"430","volume-title":"Viral and Rickettsial Infections of Man","author":"D Bodian","year":"1965","unstructured":"Bodian D, Horstmann DH. Polioviruses. In: Horsfall FL, Tamm I, editors. Viral and Rickettsial Infections of Man. Philadelphia: Lippincott; 1965. p. 430\u201373."},{"key":"1587_CR42","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0042-6822(89)90183-9","volume":"172","author":"AJ Macadam","year":"1989","unstructured":"Macadam AJ, Arnold C, Howlett J, John A, Marsden S, Taffs F, et al. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology. 1989;172:408\u201314.","journal-title":"Virology"},{"key":"1587_CR43","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1128\/JVI.66.5.3194-3197.1992","volume":"5","author":"JM Tatem","year":"1992","unstructured":"Tatem JM, Weeks-Levy C, Georgiu A, DiMichele SJ, Gorgacz EJ, Racaniello VR, et al. A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating. J Virol. 1992;5:3194\u20137.","journal-title":"J Virol"},{"key":"1587_CR44","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3201\/eid1806.120037","volume":"18","author":"N Gumede","year":"2012","unstructured":"Gumede N, Muthambi V, Schoub BD. Immunodeficiency-associated vaccine-derived poliovirus type 3 in infant, South Africa, 2011. Emerg Infect Dis. 2012;18:992\u20134.","journal-title":"Emerg Infect Dis"},{"key":"1587_CR45","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1128\/AEM.00108-14","volume":"80","author":"A Battistone","year":"2014","unstructured":"Battistone A, Buttinelli G, Fiore S, Amato C, Bonomo P, Patti AM, et al. Sporadic isolation of Sabin-like polioviruses and high-level detection of non-polio enteroviruses during sewage surveillance in seven Italian cities, after several years of inactivated poliovirus vaccination. Appl Environ Microbiol. 2014;80:4491\u2013501.","journal-title":"Appl Environ Microbiol"},{"key":"1587_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S095026881000316X","volume":"1","author":"T Hovi","year":"2012","unstructured":"Hovi T, Shulman L, Van der Avoort H, Deshpande J, Roivainen M, DE Gourville EM. Role of environmental poliovirus surveillance in global polio eradication and beyond. Epidemiol Infect. 2012;1:1\u201313.","journal-title":"Epidemiol Infect"},{"issue":"Suppl 1","key":"1587_CR47","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1093\/infdis\/jiu222","volume":"210","author":"RW Sutter","year":"2014","unstructured":"Sutter RW, Platt L, Mach O, Jafari H, Aylward RB. The new polio eradication end game: rationale and supporting evidence. J Infect Dis. 2014;210 Suppl 1:S434\u20138.","journal-title":"J Infect Dis"},{"key":"1587_CR48","first-page":"364","volume-title":"Vaccines","author":"S Plotkin","year":"1999","unstructured":"Plotkin S, Murdin A, Vidor E. Inactivated poliovirus vaccine. In: Plotkin S, Orenstein W, editors. Vaccines. 3rd ed. 1999. p. 364\u2013408.","edition":"3"},{"key":"1587_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","volume":"163","author":"IM Onorato","year":"1991","unstructured":"Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. J Infect Dis. 1991;163:1\u20136.","journal-title":"J Infect Dis"},{"key":"1587_CR50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clim.2003.11.011","volume":"111","author":"L Fiore","year":"2004","unstructured":"Fiore L, Plebani A, Buttinelli G, Fiore S, Donati V, Marturano J, et al. Search for poliovirus long-term excretors among patients affected by agammaglobulinemia. Clin Immunol. 2004;111:98\u2013102.","journal-title":"Clin Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1587-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T01:36:43Z","timestamp":1600738603000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1587-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,10]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1587"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1587-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,10]]},"article-number":"277"}}